title: Effects of efflux pump inhibitors phenyl-arginine-beta-naphthylamide and 1-(1-naphthylmethyl)-piperazine on the antimicrobial susceptibility of Pseudomonas aeruginosa isolates from cystic fibrosis patients.
authors.forename: A Y
authors.initials: AY
authors.lastname: Coban
authors.forename: Y
authors.initials: Y
authors.lastname: Tanriverdi Cayci
authors.forename: Z
authors.initials: Z
authors.lastname: Erturan
authors.forename: B
authors.initials: B
authors.lastname: Durupinar
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D003550:Cystic Fibrosis / Q000382:microbiology*; D004151:Dipeptides / Q000494:pharmacology*; D006801:Humans; D008826:Microbial Sensitivity Tests; D010879:Piperazines / Q000494:pharmacology*; D011552:Pseudomonas Infections / Q000382:microbiology*; D011550:Pseudomonas aeruginosa / Q000187:drug effects* / Q000302:isolation & purification
chemical_list: C511391:1-(1-naphthylmethyl)piperazine; D000900:Anti-Bacterial Agents; D004151:Dipeptides; D010879:Piperazines; C419365:phenylalanine arginine beta-naphthylamide